Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Post by rgonlyfactsplson May 01, 2012 8:33pm
276 Views
Post# 19859283

A few factoids about Pfizer's...

A few factoids about Pfizer's...
Animal Health business with focus on its companion animal care business. Hopefully the "copy&pastes" come out okay and links still live. And, hopefully of value.... as some good learning for me anyways. Enjoy the evening! rg
First, quick reference to their canine cancer treatment...
Palladia is Pfizer's canaine cancer therapy approved in 2009 per following press release:
June 03, 2009 09:36 AM
MONTREAL--()--Pfizer Animal Health today announced that the U.S. Food and Drug Administration (FDA) has approved the first canine cancer therapy in the U.S. – PALLADIATM (toceranib phosphate) – which was developed by Pfizer to treat mast cell tumors in dogs.


8/11/2011 Pfizer Animal Health Fact Sheet

Pfizer Animal Health is a world leader in the discovery, development and manufacture of innovative animal vaccines, medicines, diagnostic products and genetic tests. Pfizer Animal Health invests more in research and development than any other animal health company, with an extensive network of research centers on four continents. We work to assure a safe, sustainable global food supply from healthy beef and dairy cattle, swine, poultry, sheep and fish. We also help dogs, cats and horses live healthier longer lives.

2011 Revenue through Q2: $2.037 billion

Full Year 2010 Revenue: $3.5 billion

Companion Animal Care
Representing approximately 40% of Pfizer Animal Health’s global revenue. Among key products:

Convenia (cefovecin sodium), an antibiotic for dogs and cats that delivers an assured, full course of treatment in one injection, avoiding the difficulty of administering daily pills. https://www.convenia.com

Revolution / Stronghold (selamectin), to protect dogs and cats from heartworms, fleas and other harmful parasites. https://www.revolutionpet.com

Palladia (toceranib phosphate), to treat mast cell tumors in dogs. https://www.palladia-pi.com

https://www.pfizer.com/files/products/pah_media_fact_sheet.pdf

Bullboard Posts